搜尋
Quanterix Corp
QTRX添加自選
4.030USD
+0.200+5.22%
收盤 08-07 16:00（美東）報價延遲15分鐘
189.84M總市值
虧損本益比TTM
關於 Quanterix Corp 公司
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.
Quanterix Corp 簡介
公司代碼QTRX
公司名稱Quanterix Corp
上市日期Dec 07, 2017
CEOToloue (Masoud)
員工數量471
證券類型Ordinary Share
年結日Dec 07
公司地址900 Middlesex Turnpike
城市BILLERICA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01821
電話16173019400
網址https://www.quanterix.com/
公司代碼QTRX
上市日期Dec 07, 2017
CEOToloue (Masoud)
Quanterix Corp公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
Mr. Jeffrey Thomas (Jeff) Elliott
Mr. Jeffrey Thomas (Jeff) Elliott
Lead Independent Director
Lead Independent Director
11.39K
-139.92%
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Garret Hampton, Ph.D.
Dr. Garret Hampton, Ph.D.
Independent Director
Independent Director
--
--
Dr. Alan Sachs, M.D., Ph.D.
Dr. Alan Sachs, M.D., Ph.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Masoud Toloue, Ph.D.
Dr. Masoud Toloue, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
355.02K
+20.48%
Mr. William P. (Bill) Donnelly
Mr. William P. (Bill) Donnelly
Executive Chairman of the Board
Executive Chairman of the Board
159.60K
+3.43%
Ms. Vandana Sriram, CPA
Ms. Vandana Sriram, CPA
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
34.95K
+3.68%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
33.84K
-47.10%
Mr. Scott Mendel
Mr. Scott Mendel
Director
Director
23.88K
+48.29%
Dr. Myla P. Lai-Goldman, M.D.
Dr. Myla P. Lai-Goldman, M.D.
Director
Director
15.04K
+53.67%
常見問題
Quanterix Corp的前五大股東是誰？
Quanterix Corp的前五大股東如下：Dr. Masoud Toloue, Ph.D.
有多少機構持有Quanterix Corp(QTRX)的股份？
截至2026Q1，共有371家機構持有Quanterix Corp的股份，合計持有的股份價值約為42.63M，占公司總股份的90.49% 。與2025Q4相比，機構持股有所增加，增幅為-4982326.00。
哪個業務部門對Quanterix Corp的收入貢獻最大？
在2026Q1，Product revenue業務部門對Quanterix Corp的收入貢獻最大，創收92.94M，占總收入的67.03% 。